Diabetic foot is a severe public health issue, yet rare studies investigated its global
epidemiology. Here we performed a systematic review and meta-analysis through searching …

The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in
low-and middle-income countries. In most developed countries, type 2 diabetes is presently …

Background Diabetes is a leading cause of chronic kidney disease (CKD) worldwide.
Optimum glycaemic control in patients with type 2 diabetes is important to minimise the risk …

Bakground The objective of this study was to determinate the prevalence of chronic kidney
disease (CKD) and the different stages of CKD in patients with type 2 diabetes mellitus …

BACKGROUND: The prevalence of chronic kidney disease, particularly in diabetic patients,
is increasing rapidly throughout the world. Nowadays, many individuals in developing …

Aims Empagliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that
inhibits renal glucose reabsorption and is being investigated for the treatment of type 2 …

Aims This cross-sectional study aimed to determine the prevalence and associated risk
factors of chronic kidney disease (CKD) in Chinese type 2 diabetic patients. Methods A total …

Background: Various findings suggest that uric acid is an inflammatory factor and may have
a role in endothelial dysfunction and act as a mediator of diabetic nephropathy. The …

Rationale & Objective Hyperglycemia exacerbates the progression of chronic kidney
disease (CKD), but most glucose-lowering therapies do not address morbidities associated …

Background Chronic kidney disease (CKD) is increasingly recognized as a global health
issue and it affects 10% to 15% of the world population. Diabetes mellitus is the leading …